Target intelligence / Profile preview

Small integral membrane protein 42 (SMIM42)

Target
SMIM42
Molecular classification
Integral membrane protein, Small membrane protein, Possible bitopic membrane protein
01

Overview

Small integral membrane protein 42 (SMIM42) is a putative protein encoded by the *SMIM42* gene, predicted to contain a single 21-amino-acid transmembrane helix. It is composed of 70 amino acids in total and is classified as a small membrane protein based on structural modeling and sequence analysis. While there is transcriptional evidence (e.g., RNA-seq) supporting testis-specific expression, there is currently no proteomic or mass spectrometry evidence confirming that SMIM42 is indeed translated in vivo. Conservation of the open reading frame is seen in placental mammals, but several mammalian lineages have lost it. The function, biological significance, and therapeutic relevance of SMIM42 remain uncertain. It is included in some gene and protein annotation sets but has been excluded from the highest-confidence lists of functional small proteins due to ambiguous coding status and lack of functional data.

Other names
SMIM42Small integral membrane protein 42
02

Mechanism of action

Null: No mechanism of action is defined because there are no known drug interactions or functional roles.

03

Biological functions

Unknown/uncertain: Predicted to encode a small, 70-amino-acid membrane protein with a single transmembrane helix.No reliable evidence for established physiological functions.
04

Disease associations

None established: No known association with specific disease roles such as cancer, inflammation, neurodegenerative, or cardiovascular disease.
05

Safety considerations

Null: No known safety concerns; the protein’s biological role and interaction profile remain uncharacterized in the context of therapy.
06

Interacting drugs

None known: There are no drugs or ligands reported to selectively interact with SMIM42.
07

Biomarkers

Null: SMIM42 is not reported as a biomarker for any therapeutic or diagnostic purposes.

Beyond the preview

Go deeper on Small integral membrane protein 42 (SMIM42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small integral membrane protein 42 (SMIM42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call